Contribution of Clostridium difficile infection to the development of lower gastrointestinal adverse events during autologous stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|4|566-573

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.4, 2015-08, pp. : 566-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The long‐term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 371-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 6, 2017-03 ,pp. : 651-657

Cambridge University Press

Access to resources Recommend Favorite

Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection

By Borody Thomas J   Brandt Lawrence J   Paramsothy Sudarshan   Agrawal Gaurav  

Expert Review of Anti-Infective Therapy, Vol. 11, Iss. 5, 2013-05 ,pp. : 447-449

Informa Healthcare

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1112-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite